Challenges of drug development in pediatric oncology. A perspective from the pharmaceutical industry

被引：0
|
作者：
Capdeville, R. [1 ]
机构：
[1] Novartis AG, Clin Oncol, Basel, Switzerland
来源：
EJC SUPPLEMENTS | 2006年 / 4卷 / 12期
关键词：
D O I：
10.1016/S1359-6349(06)70241-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
236
引用
收藏
页码：77 / 77
页数：1
相关论文
共 50 条
  • [1] Challenges in Pediatric Drug DevelopmentA Pharmaceutical Industry Perspective
    Klaus Rose
    Pediatric Drugs, 2009, 11 (1) : 57 - 59
  • [2] Radiopharmaceuticals for Oncology Drug Development: A Pharmaceutical Industry Perspective
    Murphy, Philip S.
    Bergstrom, Mats
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (09) : 957 - 965
  • [3] Current Challenges in Drug Safety: A Perspective from the Pharmaceutical Industry
    Daniels, S.
    DRUG SAFETY, 2010, 33 (10) : 911 - 911
  • [4] Aftercare and transition in pediatric oncology. From the perspective of survivors
    Schneider, Carina
    PADIATRIE UND PADOLOGIE, 2016, 51 : S39 - S43
  • [5] Drug-induced pneumonitis in pediatric oncology.
    Boccon-Gibod, L
    ANNALES DE PEDIATRIE, 1998, 45 (04): : 272 - 275
  • [6] AQUACULTURE DRUG DEVELOPMENT - A PHARMACEUTICAL-INDUSTRY PERSPECTIVE
    BELEAU, MH
    VETERINARY AND HUMAN TOXICOLOGY, 1991, 33 : 11 - 13
  • [7] Pharmaceutical industry perspective on MPS technologies for drug development
    Gan, Jinping
    DRUG METABOLISM REVIEWS, 2016, 48 : 20 - 20
  • [8] Biological reactive intermediates in drug discovery and development - A perspective from the pharmaceutical industry
    Baillie, TA
    Kassahun, K
    BIOLOGICAL REACTIVE INTERMEDIATES VI: CHEMICAL AND BIOLOGICAL MECHANISMS IN SUSCEPTIBILITY TO AND PREVENTION OF ENVIRONMENTAL DISEASES, 2001, 500 : 45 - 51
  • [9] Drug development in pediatric oncology - challenges and opportunities - reflections from European regulators
    Karres, Dominik
    O'Connor, Daniel
    Norga, Koen
    Siapkara, Angeliki
    EXPERT OPINION ON ORPHAN DRUGS, 2018, 6 (09): : 519 - 526
  • [10] Therapeutic exercise in pediatric oncology. Development of a pilot project
    Beulertz, J.
    Bloch, W.
    Prokop, A.
    Baumann, F. T.
    MONATSSCHRIFT KINDERHEILKUNDE, 2013, 161 (04) : 330 - 335
12345